Stress ulcer prophylaxis: It's that same old wine in a brand new bottle

Critical Care Medicine

Volumn 42, Issue 4, 2014, Pages 979-980

  Erstad, Brian L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

cost effectiveness; critical care; histamine 2 receptor antagonist; proton pump inhibitor; stress ulcer

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE; SUCRALFATE;

CLINICAL TRIAL (TOPIC); COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DRUG COST; EDITORIAL; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTENSIVE CARE UNIT; MORTALITY; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STRESS ULCER; VENTILATED PATIENT;

CRITICAL ILLNESS; HISTAMINE H2 ANTAGONISTS; HUMANS; INTENSIVE CARE UNITS; PEPTIC ULCER; PROTON PUMPS; STRESS, PHYSIOLOGICAL;

EID: 84897837799     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000065     Document Type: Editorial

References (17)

1. ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health-Syst Pharm 1999; 56:347-379
2. Cook DJ, Fuller HD, Guyatt GH, et al: Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994; 330:377-381
3. Cook D, Guyatt G, Marshall J, et al: A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 1998; 338:791-797
4. Marik PE, Vasu T, Hirani A, et al: Stress ulcer prophylaxis in the new millennium: A systematic review and meta-analysis. Crit Care Med 2010; 38:2222-2228
5. Lin PC, Chang CH, Hsu PI, et al: The effcacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: A meta-analysis. Crit Care Med 2010; 38:1197-1205
6. Barkun AN, Bardou M, Pham CQ, et al: Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: A meta-analysis. Am J Gastroenterol 2012; 107:507-520; quiz 521
7. Alhazzani W, Alenezi F, Jaeschke RZ, et al: Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: A systematic review and meta-analysis. Crit Care Med 2013; 41:693-705
8. Kantorova I, Svoboda P, Scheer P, et al: Stress ulcer prophylaxis in critically ill patients: A randomized controlled trial. Hepatogastroenterology 2004; 51:757-761
9. Zimmerman JE, Kramer AA, Knaus WA: Changes in hospital mortality for United States intensive care unit admissions from 1988 to 2012. Crit Care 2013; 17:R81
10. Cook DJ, Griffth LE, Walter SD, et al; Canadian Critical Care Trials Group: The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 2001; 5:368-375
11. Erstad BL, Camamo JM, Miller MJ, et al: Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center. Crit Care Med 1997; 25:1678-1684
12. Pitimana-aree S, Forrest D, Brown G, et al: Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care. Intensive Care Med 1998; 24:217-223
13. MacLaren R, Campbell J: Cost-Effectiveness of Histamine Receptor-2 Antagonist Versus Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients. Crit Care Med 2014; 42:809-815
14. Siegel JE, Weinstein MC, Russell LB, et al: Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine. JAMA 1996; 276:1339-1341
15. Garrison LP Jr, Mansley EC, Abbott TA 3rd, et al: Good research practices for measuring drug costs in cost-effectiveness analyses: A societal perspective: The ISPOR Drug Cost Task Force report-Part II. Value Health 2010; 13:8-13
16. American Thoracic Society: Understanding costs and cost-effectiveness in critical care. Am J Resp Crit Care Med 2002; 165:540-550
17. Barkun AN, Adam V, Martel M, et al: Cost-effectiveness analysis: Stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists. Value Health 2013; 16:14-22